Alibaba Health Information Technology
Alibaba Health Information Technology Limited is a Chinese healthcare technology enterprise providing pharmaceutical e-commerce and digital health platform services. Operating as the flagship healthcare platform of Alibaba Group, the company organizes operations into Direct Health E-commerce, E-commerce Platform Services, and Digital Healthcare Services. Key services comprise online prescription and OTC drug sales, medical device retail, telemedicine consultations, and medical tracking networks. Primary revenue is generated through direct online sales of health products and merchant commission fees on its platform. Alibaba Health holds a leading market position within Mainland China's pharmaceutical e-commerce and digital health markets. The company is headquartered in Hong Kong, and its shares trade on the Stock Exchange of Hong Kong.
13 of the funds FundTelligence covers report a position in Alibaba Health Information Technology.
- Legal name
- Alibaba Health Information Technology Ltd.
- Sector
- Health Care
- Country
- China
- Funds holding it
- 13
Funds holding Alibaba Health Information Technology
- Nordea Emerging Markets Sustainable Enhanced — Nordea Funds · 0.07 % (full portfolio disclosed, September 2026)
- Nordea Emerging Markets Enhanced — Nordea Funds · 0.04 % (full portfolio disclosed, September 2026)
- Lannebo Emerging Markets — Lannebo · 0.03 % (full portfolio disclosed, June 2026)
- Handelsbanken Asia Tema — Handelsbanken · 0.02 % (full portfolio disclosed, August 2026)
- Danske Invest Global Emerging Markets Index Restricted — Danske Invest · 0.02 % (full portfolio disclosed, July 2026)
- KLP AksjeFremvoksende Markeder Indeks — KLP · 0.02 % (full portfolio disclosed, June 2026)
- BlackRock iShares MSCI EM IMI Screened UCITS ETF — BlackRock · 0.02 % (full portfolio disclosed, October 2026)
- DNB Emerging Markets Index — DNB · 0.01 % (full portfolio disclosed, September 2026)
Showing the 8 largest of 13 funds holding it.